HK1118012A - Formula ions and treatments for well-being - Google Patents

Description

Health preparation and treatment method

Technical Field

The present invention relates to a health preparation and a treatment method. The present invention relates generally to formulations and methods of treatment for human health care, but may also be used for unrelated conditions, such as alopecia.

Background

Herbal extracts and formulations have long been used and/or suggested for use in human health care. The extracts and preparations have different medicinal effects. Generally, such treatments are either local or systemic, but sometimes both are used simultaneously. In the art, the term "health" is used to refer to the general health, in particular physical health and well-being, of a person. Recently, the term "physical and mental health" has been newly created, but these terms are not strictly defined in the connotation. Unless the context indicates otherwise, the term "healthy" in this specification is intended to encompass the meaning of such concepts including those described above.

It is an object of the present invention to provide formulations and methods of treatment for human health which overcome one or more of the deficiencies of the prior art. Other objects and advantages of the present invention will become apparent from the following description.

Disclosure of Invention

In view of the foregoing, a first aspect of the present invention resides broadly in a formulation for human health care, the formulation comprising:

extracts of the following herbs:

polygonum multiflorum (Polygonum multiflorum);

american ginseng (Panax quinquefolium);

ginkgo biloba (Gingko biloba); and

equisetum arvense (Equisetum arvense);

beta-sitosterol;

methylsulfonylmethane;

soy isoflavones;

l-arginine;

inositol;

nicotinic acid;

pantothenic acid or salts thereof;

alpha-tocopherol;

biotin;

pyridoxine hydrochloride;

zinc (or amino acid chelates thereof); and

colostrum.

In a second aspect, the invention resides broadly in a formulation for human health, the formulation comprising a 5-alpha reductase production inhibitor and methylsulfonylmethane.

Preferably, the inhibitor of 5-alpha reductase production is selected from one or more phytosterols, especially the equivalent of beta sitosterol. Alternatively, or in addition, the inhibitor of 5-alpha reductase production may comprise an extract of Pterocarpus serpentinus (Serenoa repens) or Pterocarpus marsupium (Saw palmetto). The herbal extract may also include Pygeum repens. The formulation may also include thiamine. The formulation may also include riboflavin.

In a third aspect, the invention resides broadly in a formulation for human health care, the formulation comprising:

inhibitors of 5-alpha reductase production;

methylsulfonylmethane; and

an extract of the herbal polygonum multiflorum.

In a fourth aspect, the invention resides broadly in a formulation for human health care, the formulation comprising:

inhibitors of 5-alpha reductase production;

methylsulfonylmethane;

an extract of the herbal polygonum multiflorum; and

colostrum.

In a fifth aspect, the invention resides broadly in a formulation for human health care, the formulation comprising:

inhibitors of 5-alpha reductase production;

methylsulfonylmethane;

an extract of the herbal polygonum multiflorum; and

l-arginine.

In a sixth aspect, the invention resides broadly in a formulation for human health care, the formulation comprising:

inhibitors of 5-alpha reductase production;

methylsulfonylmethane;

an extract of the herbal polygonum multiflorum;

l-arginine; and

colostrum.

In a seventh aspect, the invention resides broadly in a formulation for human health care, the formulation comprising:

inhibitors of 5-alpha reductase production;

methylsulfonylmethane;

an extract of the herbal polygonum multiflorum;

l-arginine;

colostrum; and

ginkgo.

In an eighth aspect, the present invention resides broadly in a formulation for human health care, the formulation comprising:

an extract of the herbal polygonum multiflorum;

inhibitors of 5-alpha reductase production;

methylsulfonylmethane; and

colostrum.

Preferably, the formulation includes an amino acid chelated zinc. Preferred formulations include ginkgo biloba. More preferably, the formulation includes the amino acid chelated zinc and ginkgo biloba. It is further preferred that the formulation comprises an extract of any one or more of the following herbs:

polygoni Multiflori radix;

ginkgo biloba;

herba Equiseti Arvinsis;

american ginseng.

It is further preferred that the formulation comprises any one or more of the following:

one or more soy isoflavones;

l-arginine;

inositol;

nicotinic acid;

biotin;

calcium pantothenate;

d-alpha-tocopherol;

pyridoxine hydrochloride.

Preferably, the colostrum is bovine colostrum. However, it will be appreciated that colostrum from other mammals may also be used, particularly colostrum which is effective in ameliorating the reduction of growth hormone ("GH") and/or insulin-like growth factor 1 ("IGF-1") during aging. Preferably, the relevant selected amount of each component provided is that amount which provides efficacy in its known performance characteristics.

In a ninth aspect, the invention resides broadly in a formulation for human health, the formulation, when dosed in a range of between 3g and 8g, comprising:

phytosterol 200mg to 2500 mg;

600mg to 2600mg of an equivalent of Polygonum multiflorum root (the quaternary equivalent of Polygonum multiflorum root 4: 1 in 70% EW) extracted with 70% aqueous ethanol at 4: 1;

methylsulfonylmethane 500mg to 2000 mg; and

bovine colostrum 500mg to 2000 mg.

Preferably, the preparation further comprises 50mg to 1000mg of an equivalent of the ginkgo biloba extract extracted with 70% aqueous ethanol at a ratio of 50: 1. Preferably, the formulation further comprises 10mg to 40mg of a 20% equivalent of the zinc amino acid chelate. More preferably, the formulation includes both ginkgo biloba and zinc amino acid chelate. It is also preferred that any one or more of the following ingredients be included in the formulation:

120mg to 500mg of arginine;

biotin 0.7mg to 5 mg;

5mg to 30mg of nicotinic acid;

10mg to 400mg of calcium pantothenate;

pyridoxine hydrochloride from 10mg to 400 mg;

200IU to 800IU of d-alpha-tocopherol; and

60mg to 500mg of anhydrous colloidal silica.

It is also preferred that the formulation further comprises any one or more of the following:

an equivalent of soybean (Glycine Max, soy) seed extracted with 75% aqueous ethanol at 65: 1, 80mg to 3250 mg;

50mg to 1000mg of the same amount of the American ginseng root extract extracted by 15% ethanol water solution according to the ratio of 3: 1;

50mg to 1000mg of an equivalent of an Equisetum arvense extract extracted with 100% water at a ratio of 4: 1;

inositol 70 mg-300 mg.

Preferably, the phytosterol is 200mg to 2500 mg. More preferably, the phytosterol is 200mg to 1000 mg. Preferably, the ginkgo extract is 50mg to 1000 mg. More preferably, the ginkgo extract is 50mg to 500 mg. Preferably, the American ginseng root extract is 50mg to 1000 mg. More preferably, the American ginseng root extract is 50mg to 500 mg. Preferably, the Equisetum arvense extract is 50mg to 1000 mg. More preferably, the Equisetum arvense extract is 50mg to 500 mg. Preferably, the bovine colostrum is 50mg to 2000 mg. More preferably, the bovine colostrum is 500mg to 1000 mg. Preferably, biotin is 0.7mg to 3 mg. Preferably, the pyridoxine hydrochloride is between 100mg and 400 mg. 6 to 26mg of Trusil natural lemon/lime or equivalent flavoring agent may also be added to the formulation. 125mg to 500mg of fructose or a sweetener equivalent thereto may also be added to the preparation.

In a tenth aspect, the invention resides broadly in a formulation for use in the health care of a human patient, the formulation comprising:

providing a biological sulfur nutritional supplement of biologically active sulfur;

one or more dihydrotestosterone blocking components for inhibiting the binding of dihydrotestosterone to a receptor site and/or inhibiting the effect of 5-alpha-reductase in converting testosterone to dihydrotestosterone;

one or more capillary blood flow promoting agents for promoting capillary blood flow;

a growth factor component that promotes cell growth by ameliorating the reduction of growth hormone ("GH") and/or insulin-like growth factor 1 ("IGF-1") during aging;

an amino acid component having at least some of all the essential amino acids for human metabolism; and

at least the minerals silicon and zinc are introduced into the mineral composition of the patient.

Preferably, the formulation comprises a vitamin B formulation having at least a portion of vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B8, vitamin B_XAnd vitamin component of vitamin E.

Preferably, the ingredient is selected from the group consisting of phytosterols, polygonum multiflorum root (fo-ti), soybean seed, ginkgo biloba, american ginseng root, field horsetail, inositol, methylsulfonylmethane, bovine colostrum, arginine, biotin, niacin, calcium pantothenate, pyridoxine hydrochloride, d-alpha-tocopherol acetate, Trusil natural lemon/lime or a flavoring equivalent thereto, fructose or a sweetening agent equivalent thereto, anhydrous colloidal silica and zinc amino acid chelate, as indicated in the ninth aspect of the invention described in the present description, said substances being formulated in a dose ranging from 3g to 8 g.

Preferably, at least one capillary flow promoting agent is used to promote the opening of potassium channels in a patient's cell membrane. Preferably the amino acid component comprises isoflavones and/or phytosterols. More preferably, the amino acid composition comprises phytoestrogens (phytoestrogens). More preferably, the amino acid component comprises genistein. In another preferred form the amino acid component comprises daidzein (daidzein). The vitamin and mineral components may be comprised of components from one or more sources. For example, silicon minerals are available from the herb known as equisetum, horsetail. The zinc mineral can be contained in zinc citrate.

Preferably, the preparation of the oral formulation comprises: the ingredients are formed into individual ingredient powders, which are mixed and packaged into packets of predetermined dosages. A preferred dosage package contains 3g to 9g of the mixed powder. In a particularly preferred form, the dose is 5.5g of powder. In this form the mixed powder is preferably administered dissolved in a drinking material, for example water, but it will be appreciated that various drinkable liquids are suitable. It is recommended that 200g to 1000g of powder is effective when administered monthly in accordance with the method of the invention. Of course, colouring and/or flavouring additives may be included, as well as dispersing and/or emulsifying agents, thickening agents, preservatives and the like.

The resulting powders may contain different flavoring and/or coloring agents. In addition, the powders may be flavored differently for different diluents, e.g., fruity for mixing with water, while vanilla, chocolate or caramel flavors for mixing in dairy or non-dairy, milk-like substances.

In an eleventh aspect, the invention resides broadly in a medical formulation for human health care, the formulation comprising:

extracts of the following herbs:

polygoni Multiflori radix;

ginkgo biloba;

herba Equiseti Arvinsis;

american ginseng;

methylsulfonylmethane;

l-arginine;

an inhibitor of 5-alpha-reductase production;

one or more soy isoflavones;

inositol;

nicotinic acid;

biotin;

calcium pantothenate;

d-alpha-tocopherol;

pyridoxine hydrochloride;

amino acid chelated zinc; and

colostrum.

The composition of the medical preparation is preferably selected substantially in accordance with the limitations set forth in the specification with respect to the corresponding components of the other corresponding aspects of the invention.

Preferably, the colostrum is bovine colostrum. However, it will be appreciated that colostrum of other mammalian sources may also be used, particularly colostrum which is effective in ameliorating the reduction of growth hormone ("GH") and/or insulin-like growth factor 1 ("IGF-1") during aging. Preferably, the relevant selected amount of each component provided is that amount which provides efficacy in terms of its known performance characteristics.

In a twelfth aspect, the invention resides broadly in a formulation for patient care, said formulation, when dosed in a range of between 3g and 8g, comprising:

phytosterol 200mg to 2500 mg;

600mg to 2600mg of equivalent polygonum multiflorum root extracted with 70% ethanol water solution according to a ratio of 4: 1;

800mg to 3250mg of equivalent of soybean seeds extracted by 75% ethanol water solution according to a ratio of 65: 1;

50 mg-1000 mg of the equivalent of the ginkgo biloba extract extracted with 70% ethanol water solution according to the ratio of 50: 1

50mg to 1000mg of the same amount of the American ginseng root extract extracted by 15% ethanol water solution according to the ratio of 3: 1;

50mg to 1000mg of an equivalent of an Equisetum arvense extract extracted with 100% water at a ratio of 4: 1;

inositol 70 mg-300 mg;

methylsulfonylmethane 500mg to 2000 mg;

bovine colostrum 500mg to 2000 mg;

120mg to 500mg of arginine;

biotin 0.7mg to 5 mg;

5mg to 30mg of nicotinic acid;

calcium pantothenate in an amount of 100mg to 400 mg;

pyridoxine hydrochloride from 10mg to 400 mg;

200IU to 800IU of d-alpha-tocopheryl acetate;

6 to 26mg or equivalent of Trusil natural lemon/lime flavoring;

fructose 125 to 500mg or a sweetener equivalent thereto;

60-500 mg of anhydrous colloidal silica;

amino acid Zinc chelate 20% equivalent amino acid Zinc chelate 10mg to 40 mg.

It will be understood that the sweetening and flavoring agents are not required for the efficacy of the formulation.

In a thirteenth aspect, the invention resides broadly in a method of improving the health of a human patient, the method comprising the steps of:

preparing a predetermined amount of a preparation consisting of extracts of the herbs polygonum multiflorum, panax quinquefolium, ginkgo biloba, and equisetum arvense; beta-sitosterol; methylsulfonylmethane; soy isoflavones; l-arginine; inositol; nicotinic acid; pantothenic acid or salts thereof; alpha-tocopherol; biotin; pyridoxine hydrochloride; zinc (or its amino acid chelate) and colostrum; and is

The amount is prepared for oral administration to a human patient.

In a fourteenth aspect, the invention resides broadly in a method of improving the health of a human patient, the method comprising the steps of:

preparing a predetermined amount of a formulation consisting of: providing a biological sulfur nutritional supplement of biologically active sulfur; one or more capillary blood flow promoting agents for promoting capillary blood flow; a growth factor component that promotes cell growth by ameliorating the reduction of growth hormone ("GH") and/or insulin-like growth factor 1 ("IGF-1") during aging; an amino acid component having at least some of all the essential amino acids for human metabolism; a mineral component capable of introducing at least the minerals silicon and zinc into a patient; and has at least a portion of vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B8, vitamin B_XAnd vitamin E; and is

The predetermined amount is prepared for oral administration to a human patient.

Although the formulations have been found to have enhanced efficacy when used in a systemic delivery manner, it should be understood that the methods of the present invention are not so limited.

Preferably, at least one capillary blood flow promoting agent is used to promote the opening of potassium channels in the patient's cell membranes. Preferably the amino acid component comprises isoflavones and/or phytosterols. More preferably, the amino acid composition comprises phytoestrogens. More preferably, the amino acid component comprises genistein. In another preferred form, the amino acid component comprises daidzein. The vitamin and mineral components may be comprised of components from one or more sources. For example, silicon minerals are available from the herb known as equisetum equiseti, equisetum arvense. The zinc mineral can be contained in zinc citrate.

Preferably, the preparation of the oral formulation comprises: the ingredients are formed into individual ingredient powders, which are mixed and packaged into packets of predetermined dosages. A preferred dosage package contains 2g to 10g of the mixed powder. In a particularly preferred form, the dose is 5.5g of powder. Another preferred dosage package comprises a supply of powder in an amount within the above-mentioned range for two times a day, for one week or one month or a part thereof. In this form the mixed powder is preferably administered dissolved in a drinking material, for example water, but it will be appreciated that various drinkable liquids are suitable. Of course, colouring and/or flavouring additives, as well as dispersing and/or emulsifying agents, thickening agents, preservatives and the like may also be included.

Detailed Description

In order that the invention may be more readily understood and put into practical effect, reference will now be made to one or more examples of the invention and in which at least some aspects and embodiments of the invention will be described by way of experimental study in the course of the invention.

Example 1

A batch was prepared according to the contents listed in table 1 below.

Ingredients (and concentration)	Quantity of indication	mg	mg/dose	Excess of	mg/g (including excess)	Amount for mixing (kg)
							Phytosterol (33% beta-sitosterol)Alcohol equivalents)	500.00	303	1515	3％	312.09	35.344
Polygonum multiflorum (foti) root 4: 1, 70% EW extraction	1350.00	67.5	337.5	5％	70.88	8.027
							65: 1, 75% EW extraction of Soybean seeds	1625.00	5	25	0％	5.00	0.566
Ginkgo biloba leaf extract (50: 1, 70% EW extract)	100.00	0.4	2	5％	0.42	0.048
							American ginseng root extract (3: 1, 15% EW extract)	100.05	6.67	33.35	5％	7.00	0.793
Equisetum arvense extract (horsetail) (4: 1, 100% water extract)	100.00	5	25	5％	5.25	0.595
							Inositol	150.00	30	150	5％	31.50	3.567
Methylsulfonylmethane (MSM)	1000.00	200	1000	5％	210.00	23.783
							Colostrum (ox)	1000.00	200	1000	5％	310.00	23.783

Arginine	250.00	50	250	0％	50.00	5.663
							Biotin	1.40	0.28	1.4	5％	0.29	0.033
Nicotinic acid	15.00	3	15	5％	3.15	0.357
							Calcium pantothenate	200.00	40	200	4％	41.67	4.719
Pyridoxine hydrochloride	25	5	25	5％	5.24	0.595
							d-alpha-tocopheryl acetate (vitamin E acetate dry powder)	400IU	107.2	536	5％	112.56	12.747
Trusil natural lemon/lime	13	2.6	13	5％	2.73	0.309
							Fructose	250	50	250	0％	50.00	5.663
Anhydrous colloidal silica	125	25	125	0％	25.00	2.831
							Amino acid chelated zinc 20%	20	20	100	5％	21.00	2.378
Total of	6804.45	1120.65	5603.25			131.799

The prepared formulations were tested for health in a number of individuals and compared to placebo. The test results indicate that the formulation is effective for improving health.

Example 2

A batch was prepared according to the contents set forth in the table below.

Composition (I)	Marked quantity (mg/5g)	mg	mg/dose
				Phytosterols (33% beta-sitosterol equivalent)	125.00	75.75	378.75
Polygonum multiflorum (Fo Ti) root 4: 1, 70% EW extraction	337.50	16.88	84.38
				65: 1, 75% EW extraction of Soybean seeds	406.25	1.25	6.25
Ginkgo biloba leaf extract (50: 1, 70% EW extract)	25.00	0.10	0.50
				American ginseng root extract (3: 1, 15% EW extract)	25.01	1.67	8.34
Equisetum arvense extract (horsetail)	25.00	1.25	6.25

(4: 1, 100% water extraction)
				Inositol	37.50	7.50	37.50
Mesyl radicalMethane (MSM)	250.00	50.00	250.00
				Colostrum (ox)	250.00	50.00	250.00
Arginine	62.50	12.50	62.50
				Biotin	0.35	0.07	0.35
Nicotinic acid	3.75	0.75	3.75
				Calcium pantothenate	50.00	10.00	50.00
Pyridoxine hydrochloride	6.25	1.25	6.25
				d-alpha-tocopheryl acetate (vitamin E acetate dry powder)	100IU	26.80	134.00
Trusil natural lemon/lime	3.25	0.65	3.25
				Fructose	62.50	12.50	62.50
Anhydrous colloidal silica	31.25	6.25	31.25
				Amino acid chelated zinc 20%	5.00	5.00	25.00
Total of	1706.11	280.16	1400.81

The prepared formulations were tested for health in a number of individuals and compared to placebo. The test results indicate that the formulation is effective for improving health.

Example 3

A batch was prepared according to the contents listed in table 3 below.

Composition (I)	Marked quantity (mg/5g)	mg	mg/dose
				Phytosterols (33% beta-sitosterol equivalent)	250.00	151.50	757.50
Polygonum multiflorum (Fo Ti) root 4: 1, 70% EW extraction	675.00	33.75	168.75
				65: 1, 75% EW extraction of Soybean seeds	812.50	2.50	12.50
Ginkgo biloba leaf extract (50: 1, 70% EW extract)	50.00	0.20	1.00
				American ginseng root extract (3: 1, 15% EW extract)	50.03	3.34	16.68

Equisetum arvense extract (horsetail) (4: 1, 100% water extract)	50.00	2.50	12.50
				Inositol	75.00	15.00	75.00
Methylsulfonylmethane (MSM)	500.00	100.00	500.00
				Colostrum (ox)	500.00	100.00	500.00
Arginine	125.00	25.00	125.00
				Biotin	0.70	0.14	0.70
Nicotinic acid	7.50	1.50	7.50
				Calcium pantothenate	100.00	20.00	100.00
Pyridoxine hydrochloride	12.50	2.50	12.50
				d-alpha-tocopheryl acetate (vitamin E acetate dry powder)	200IU	53.60	268.00
Trusil natural lemon/lime	6.50	1.30	6.50
				Fructose	125.00	25.00	125.00
Anhydrous colloidal silica	62.50	12.50	62.50
				Amino acid chelated zinc 20%	10.00	10.00	50.00
Total of	3412.23	560.33	2801.63

The prepared formulations were tested for health in a number of individuals and compared to placebo. The test results indicate that the formulation is effective for improving health.

Example 4

A batch was prepared according to the contents set forth in table 4 below.

Composition (I)	Marked quantity (mg/5g)	mg	mg/dose
				Phytosterols (33% beta-sitosterol equivalent)	1000.00	606.00	3030.00
Polygonum multiflorum (Fo Ti) root 4: 1, 70% EW extraction	2700.00	135.00	675.00
				65: 1, 75% EW extraction of Soybean seeds	3250.00	10.00	50.00
Ginkgo biloba leaf extract (50: 1, 70% EW extract)	200.00	0.80	4.00
				The American ginseng root extract (3: 1,	200.10	13.34	66.70

15% EW extraction)
				Equisetum arvense extract (horsetail) (4: 1, 100% water extract)	200.00	10.00	50.00
Inositol	300.00	60.00	300.00
				Methylsulfonylmethane (MSM)	2000.00	400.00	2000.00
Colostrum (ox)	2000.00	400.00	2000.00
				Arginine	500.00	100.00	500.00
Biotin	2.80	0.56	2.80
				Nicotinic acid	30.00	6.00	30.00
Calcium pantothenate	400.00	80.00	400.00
				Pyridoxine hydrochloride	50.00	10.00	50.00
d-alpha-tocopheryl acetate (vitamin E acetate dry powder)	800IU	214.40	1072.00
				Trusil natural lemon/lime	26.00	5.20	26.00
Fructose	500.00	100.00	500.00
				Anhydrous colloidal silica	250.00	50.00	250.00
Amino acid chelated zinc 20%	40.00	40.00	200.00
				Total of	13648.90	2241.30	11206.50

The prepared formulations were tested for health in a number of individuals and compared to placebo. The test results indicate that the formulation is effective for improving health.

In use, the formulations and methods of the present invention may be used to enhance "physical and mental health" or wellness in human patients. The formulations of the present invention are believed to contribute to a more potent synergistic result by way of a synergistic effect compared to single ingredient or single modality treatment. The beneficial effects of this treatment may be considered to include correction of problems of abnormal circulatory flow or low circulatory flow around and in the cardiovascular system, and/or abnormal hormonal or dietary balance.

The root extract of Polygonum multiflorum (Fo-ti) is also called "He Shou Wu". fo-ti root is considered a tonic for endocrine glands, liver and kidney. fo-ti contains a number of vitamins and minerals essential to hair, including vitamin B complex, vitamin C, silicon, zinc and vitamin a. In china, polygonum multiflorum is used in particular as a tonic and for prolonging life. Traditional Chinese medicine records that the medicine is a 'qi tonifying medicine', namely a herbal medicine which is beneficial to the immune system and has a hormone effect. It is a traditional therapeutic agent for the treatment of poor sleep. The herb is considered a slow-acting sedative, and its benefits are felt over several months. Clinical observation of its use shows that it can refresh brain, relieve insomnia, vertigo and constipation, and can be used as a tonic for blood, liver and kidney, and is commonly used for prolonging life and sexual function. Recent evidence suggests that it is effective against hypertension and hardening of arteries and veins.

In the case of colostrum, it is a substance produced by almost all mammals from the mother shortly after birth of their offspring. Medical research shows that bovine colostrum can provide the most important immune and growth factors for adults, children and animals. Because colostrum is a food and not a drug, it is not toxic and can be used without any known side effects. Colostrum clinical studies conducted by most medical institutions and universities indicate that a clinically active bovine supplement obtained from cows can naturally stimulate the nutrient-rich nature of the production thereof by the mother after birth of the newborn offspring. Colostrum provides a supranutritional mixture of important proteins, antibodies, antioxidants, immunoglobulins, growth factors, vitamins, minerals, enzymes and amino acids. The highly nutritious nature of colostrum makes it impossible to produce it in sustained amounts throughout lactation. Colostrum, which is initially produced shortly after delivery, is itself supplied to provide early promotion of newborn mammalian offspring. Colostrum is also believed to have an effect on fighting against and even reversing signs of ageing.

According to Rona Zoltan, colostrum is indeed the most practical natural anti-infective protectant. It is completely natural, has no side effects, and is an excellent substitute for hundreds of drugs. Colostrum has been confirmed by Ayurvedic (Ayurvedic) physicians to be beneficial to the body and to have therapeutic and healing activity bovine colostrum has been used in india for thousands of years. Mammals produce colostrum, a powerful, nutrient-rich fluid shortly after delivery. Colostrum provides a multi-nutrient mixture of important proteins, antibodies, antioxidants, immunoglobulins, growth factors, vitamins, minerals, enzymes and amino acids. Colostrum is the most primitive life-sustaining food-bovine colostrum, when properly handled, contains over thirty-seven immune factors as well as eight growth factors.

Methylsulfonylmethane is a natural source of sulfur in metabolic processes. Sulfur is important for collagen formation and is also required for a variety of body structure molecules. It has a number of benefits including joint and tissue health, anti-allergy and asthma, nutritional support for healthy energy levels, and toxin elimination. Methylsulfonylmethane is known as a "natural cosmetic mineral" because it is believed to maintain hair shine and smoothness, maintain a bright and youthful skin tone, and is believed to contribute to collagen synthesis. This material is ubiquitous in keratin, a tough protein (toughprotein) material essential for the health and maintenance of hair, nails and skin, including anti-aging. Some of the functional properties of methylsulfonylmethane include improving the microcirculation of the hair and scalp, maintaining the structure of proteins in the body, assisting the formation of keratin, and assisting in the production of immunoglobulins. Keratin is important for hair and nails, and immunoglobulins are responsible for maintaining the immune system.

Beta-sitosterol is obtainable, for example, from the species serenoa repens, a species of palm of america. Saw palmetto is a source of a complex, mostly unsaturated, solid alcohol (called sterols) that is widely distributed in plant and animal tissues. More specifically, the plant contains phytosterols or plant-based sterols. Sitosterol is sterol found in food (the English prefix of sitosterol is the meaning of food). Beta-sitosterol is a plant-based fat that slows the production of 5-alpha reductase and the binding of dihydrotestosterone to the androgen receptor. Dihydrotestosterone has been shown to be an undesirable derivative of the androgenic hormone testosterone. Dihydrotestosterone is present in large amounts in the hair follicles of genetically predisposed individuals and is ultimately inhibited by dihydrotestosterone. The key to the antiandrogen complex is by blocking dihydrotestosterone at the receptor site of the hair follicle. Recent intensive studies on this substance have shown that it has health benefits, such as promoting the proliferation of lymphocytes and increasing the activity of NK cells and NL cells, in addition to enhancing the immune system. This is believed to be particularly beneficial for people under physical stress, medically ill or recovering from disease. Beta-sitosterol has also been shown to lower cholesterol levels in the blood, support the prostate, reduce inflammation, heal ulcers, improve uterine conditions, reduce cramps, and provide antiviral, antibiotic and/or antimycotic agents.

Beta-sitosterol is believed to be a multi-site inhibitor of dihydrotestosterone formation and action, inhibiting dihydrotestosterone binding to a large portion of the receptor site, blocking dihydrotestosterone uptake and inhibiting the action of 5-alpha reductase, which converts testosterone to dihydrotestosterone.

Ginkgo biloba is an herbal extract that has long been used to provide natural benefits to blood vessels by ingestion or topical application. Ginkgo biloba has been shown to protect small blood vessels and microcapillary vessels from loss of tension and increased fragility. The herb can also be used for treating male and female pattern alopecia. Ginkgo is beneficial because it has the property of dilating blood vessels, especially small blood vessels, and has the particular ability to increase peripheral blood circulation, especially to the brain. Ginkgo biloba is believed to have beneficial effects in preventing systemic disorders due to insufficient blood supply. Ginkgo may also act as a strong antioxidant and may contribute to the oxidation of free radicals, which are believed to contribute to premature aging. Antioxidants also protect the eye, cardiovascular system and central nervous system. In traditional Chinese medicine, ginkgo biloba has been used to improve the heart and circulation. Herbal medicine has been used by Chinese for many centuries, and it has gradually become a routine supply in Europe, and recently also in the United states.

L-arginine is an amino acid, one of the components of proteins. In the present application, however, L-arginine, which is used as a precursor for nitric oxide production in the body, is considered to play a critical role in the metabolism of the human body and is considered to be produced from a vascular coating called vascular endothelium. The finding is particularly confusing since nitric oxide can only exist for a few seconds after its production, but after finding, researchers quickly become aware that it is likely to be a mysterious molecule that controls vasodilation. L-arginine is an essential amino acid and one of the most important supplements that can be used to improve circulation and vascular health. It is believed that nitric oxide causes vasodilation, clears blood vessels, and facilitates blood flow. Nitric oxide is thought to be involved in the opening of potassium channels (also known as "K channels"). L-arginine has been shown to promote the release of the natural Growth Hormone (GH) from the pituitary. GH has been shown to be beneficial to a healthy lifestyle and to minimize the occurrence of associated debilitations. The substance also aids in kidney control of in vivo solubles. Amino acids are said to maintain a healthy cholesterol balance, to facilitate immune function, to assist liver detoxification, to be important for muscle growth and tissue repair, to help maintain healthy blood pressure in the body, to minimize cardiovascular dysfunction, and to promote healthy heart cells.

In the case of soy isoflavones, soy and most soy products are considered the only plant food containing all the essential amino acids required by the human body, making it a "complete protein source". Soy foods do not typically contain any cholesterol and are mostly high fiber. In addition, soybeans contain a variety of vitamins, minerals, and phytochemical compounds (e.g., isoflavones), which work together to produce various health benefits. When soy isoflavone is added as a dietary supplement, it is considered to be a plant substance that favors hormonal balance. The soy product also includes phytosterols. Soy isoflavones and phytosterols are known to provide mild estrogenic effects. Soy isoflavones, which are rich in phytonutrients, help to prevent medical conditions related to aging, and from the general point of view of research, have a positive effect on hair of both women and men. Soybeans contain phytoestrogens, one of which is genistein, which has been shown to have significant 5-alpha reductase blocking activity and androgen modulating activity. The other phytoestrogen, daidzein, derived from soy also helps to block 5-alpha reductase. The substance is also believed to reduce the risk of heart disease. Soy products have been shown to reduce LDL ("bad") cholesterol and significantly increase HDL ("good") cholesterol. These substances are also believed to play an important role in the protection and maintenance of strong and healthy bones and are used in a treatment for osteoporosis.

Silica (equisetum hyemale) is considered the best mineral silica for introducing it into the food chain and is the highest content of plant origin. Silica is an important component of hair, nails, skin, bone, ligaments and collagen, and is an important herb required for the natural integrity of these structures. Silica increases the absorption of all minerals in the body. It has effects in strengthening hair follicle, stimulating and promoting hair growth. Silica tends to decline as people age. The decline may be the cause of a variety of age-related complaints, silica-related conditions such as dry hair, hair loss, dry skin, brittle hair and nails, mental allergies, poor physical performance, and the like. The brittle bone structure is enhanced by silica allowing the bone to absorb maximum calcium and clinical studies have shown that ingestion of a horsetail helps the fractured and broken bone heal faster. Modern farming produces less and less nutrients and silica in the grain. Only a few foods are considered to contain sufficient amounts of silica to provide the desired level of human diet. Horsetail is rich in silicic acid and silicates, which provide about 2-3% elemental silicon. High concentrations of silica in horsetail are highly absorbed and are used to promote calcium absorption, thereby promoting hair and bone growth and collagen formation. The herb also contains potassium, aluminum, manganese, calcium and 15 bioflavonoids (also known as vitamin P). The horsetail also supports the skeletal system by assisting in strengthening the bone and connective tissue. Silicic acid contained in equisetum is thought to contribute to circulation and establishment of the immune nervous system. It should also be noted that it may also stimulate thyroid function, help promote calcium absorption in the body, and play a role in treating broken bones, arthritis, renal and urinary tract disorders, and the like.

Inositol, a nutrient, is considered to be important for keratinocytes and is a component of cells coating hair follicles. Inositol is an important component of the B vitamins and is often referred to as vitamin B8. Inositol has an important role, not only being required for optimal overall health, but also for specific functions in the body it assists. Examples of such functions include hair growth, sedation, cholesterol reduction, and lecithin. Body inositol levels can be reduced by caffeine, sulfonamides and excess water. Inositol is present in lecithin, whole grains, citrus fruits, liver, brewers' yeast, vegetables, black syrup (black flakes), soy, etc. The B vitamins are important factors for the normal maintenance of the nervous system, the normal functioning of the cells and their energy metabolism. Any psychological and physiological stress and poor eating habits greatly increase the body's need for B vitamins. Because the B vitamins are water soluble, they cannot be stored and because they cannot be produced by anabolism, they must be routinely supplied when needed by the body. Inositol is highly hydrolysable (chemically referred to as hexahydroxycyclohexane) and it is believed that it may also provide hydroxyl groups. Inositol is considered to be very important for overall growth.

Zinc is an important mineral for the metabolism of the body and has many benefits for the health of the human body. Zinc is believed to stimulate the activity of about 100 enzymes, which are substances that promote biochemical reactions in the body. Zinc can support normal growth and maintain a healthy immune system. The minerals also help protect cells from oxidative damage, protect the red blood cell membrane against oxidation by other minerals such as copper and iron, maintain the cell membrane contents in place, and selectively allow salts and other components to flow into and out of the cell. Zinc is also present in the reproductive fluids of male mammals. The zinc in the diet is derived from beans, whole grains, shellfish, red meat (red meat), black meat (dark meat), poultry, etc.

The American ginseng root extract, also known as ginseng, is a traditional herb derived from Asia and is widely used in Asian cultures. It has many health benefits, including helping the body fight stress, increasing calmness and calmness, increasing energy, enhancing alertness reflex (alertness reflex) and tolerance, having positive effects on the cardiovascular and central nervous systems, strengthening leukocytes and antibodies, increasing their production in the bone marrow, shortening the recovery phase of disease or injury, alleviating certain effects of aging, alleviating fatigue, and acting as a safe long-term stimulant. Ginseng can also be used as a sexual stimulant for both men and women, to alleviate impotence in men and to regulate the female cycle.

Vitamin E has been shown to retard cellular senescence due to oxidation (a role arising from the maintenance of the peripheral circulation), and is one of the most important antioxidants, and its abundant presence has been associated with longevity, and it attenuates the effects of oxidative stress, and is an important part of agents for retarding cellular senescence. Vitamin E is a natural impurity antidote in the body's metabolic system. It can promote blood circulation required for healthy hair growth, but it cannot be stored in the body, and thus vitamin E deficiency can occur without the knowledge of a person. It is important for the growth of body tissue cells and blood vessels. Higher levels of vitamin E have been found in the brain tissue of longer lived people.

Each member of the B-family of vitamins has a unique structure and plays a unique role in the human body. Vitamins B1, B2, B3 and biotin are involved in different aspects of energy production, vitamin B6 is important for amino acid metabolism, and folic acid accelerates the steps required for cell division. These vitamins also each have a variety of other functions. Biotin is believed to increase the elasticity of the hair cortex to prevent breakage and thicken the cuticle of the actual hair to provide a fuller appearance and healthier effect by increasing the hair shaft diameter. Biotin is sometimes also referred to as vitamin H, butAre generally considered to be a member of the B vitamins. The vitamins promote hair growth, prevent dryness, are involved in unsaturated fat biosynthesis, and are required for energy metabolism. Folic acid is a water-soluble vitamin B complex that contributes to hair and tissue growth and cell function. Para-aminobenzoic acid (PABA) is a less known member of the B-complex family of vitamins (referred to above as vitamin B)_x). It has been shown to be an anti-leukotrichia vitamin. The vitamin has been shown to restore hair color to normal. PABA is commonly used in sunscreens. As with other vitamin B members, vitamin B1 (thiamine) plays a role in the development of blood cells and maintenance of hair, scalp and muscle tissue. Vitamin B2 (riboflavin) is involved in energy metabolism and is beneficial for vision, hair and skin health. Vitamin B3 (niacin) is important for the metabolism of carbohydrates, fats and alcohols and helps to maintain skin health and support the nervous and digestive systems. Pantothenic acid is considered to be important for the health of the skin and scalp and is essential for maintaining a good state for every body cell, without which neither carbohydrates nor fats can be converted into energy. The nutrient can be obtained from liver, kidney, egg yolk, whole grain, milk and potato. The combined effect of the substances used to formulate the formulations of the present invention is believed to provide a beneficial effect on the health and wellness of the individual and provide a trichological effect in the prevention and prophylaxis of dihydrotestosterone (a cause of hair loss and thinning in both men and women), as well as other effects. The natural nature of the formulation of the present invention is believed to provide a more effective, faster and more widespread effect than the juice called noni juice (noni juice) made from morinda citrifolia berry (Tahitian noni berry) and other health and wellness products currently available.

It is believed that while the complete combination of components described in the preferred embodiments of the present invention act in a synergistic manner to provide the best overall health and wellness benefits, it is to be understood that particular wellness benefits may also be obtained by using fewer than all of the components.

While the invention has been described with reference to specific embodiments, it will be appreciated by those skilled in the art that the invention can be embodied otherwise within the broad scope and ambit of the invention as defined by the following claims.

Claims (53)

1. A formulation for human health care, the formulation comprising:

extracts of the following herbs:

polygonum multiflorum (Polygonum multiflorum);

american ginseng (Panax quinquefolium);

ginkgo biloba (Gingko biloba); and

equisetum arvense (Equisetum arvense);

beta-sitosterol;

methylsulfonylmethane;

soy isoflavones;

l-arginine;

inositol;

nicotinic acid;

pantothenic acid or salts thereof;

alpha-tocopherol;

biotin;

pyridoxine hydrochloride;

zinc (or amino acid chelates thereof); and

colostrum.

2. A formulation for human health care, said formulation comprising a 5-alpha reductase production inhibitor and methylsulfonylmethane.

3. A formulation for health use according to claim 2, wherein the 5-alpha reductase production inhibitor is selected from one or more phytosterols.

4. A nutraceutical formulation according to claim 3, wherein said phytosterols are selected as equivalents of β -sitosterol.

5. The formulation for health care according to any one of claims 2 to 4, wherein the inhibitor of 5-alpha reductase production may comprise an extract of Pterocarpus serpens (Serenoa repens).

6. A formulation for health care according to any one of claims 2 to 4, wherein the inhibitor of 5-alpha reductase production may comprise an extract of Saw palmetto (Saw palmetto).

7. A formulation for health care according to one of claims 2 to 6, comprising an extract of the herb according to claim 1.

8. A health preparation according to claim 1 or 7, wherein said herbal extract comprises Prunus africana (Pygeum repens).

9. A nutraceutical formulation according to claims 1, 7 or 8, wherein the formulation comprises thiamine.

10. A formulation for health care according to any one of claims 1 or 7 to 9, wherein the formulation comprises riboflavin.

11. A formulation for human health care, the formulation comprising:

inhibitors of 5-alpha reductase production;

methylsulfonylmethane; and

an extract of the herbal polygonum multiflorum.

12. A formulation for human health care, the formulation comprising:

inhibitors of 5-alpha reductase production;

methylsulfonylmethane;

an extract of the herbal polygonum multiflorum; and

colostrum.

13. A formulation for human health care, the formulation comprising:

inhibitors of 5-alpha reductase production;

methylsulfonylmethane;

an extract of the herbal polygonum multiflorum; and

l-arginine.

14. A formulation for human health care, the formulation comprising:

inhibitors of 5-alpha reductase production;

methylsulfonylmethane;

an extract of the herbal polygonum multiflorum;

l-arginine; and

colostrum.

15. A formulation for human health care, the formulation comprising:

inhibitors of 5-alpha reductase production;

methylsulfonylmethane;

an extract of the herbal polygonum multiflorum;

l-arginine;

colostrum; and

ginkgo.

16. A formulation for human health care, the formulation comprising:

an extract of the herbal polygonum multiflorum;

inhibitors of 5-alpha reductase production;

methylsulfonylmethane; and

colostrum.

17. A formulation for health use according to claim 16, comprising an amino acid chelated zinc.

18. A formulation for health use according to claim 16 or 17, which comprises ginkgo biloba.

19. A formulation for health use according to any one of claims 16 to 18, wherein the formulation comprises an extract of any one or more of the following herbs:

polygoni Multiflori radix;

ginkgo biloba;

herba Equiseti Arvinsis;

american ginseng.

20. A formulation for health use according to any one of claims 16 to 19, wherein the formulation comprises any one or more of the following components:

one or more soy isoflavones;

l-arginine;

inositol;

nicotinic acid;

biotin;

calcium pantothenate;

d-alpha-tocopherol;

pyridoxine hydrochloride.

21. A nutraceutical formulation according to any of claims 1, 12, 14-20, wherein said colostrum is selected to be effective in ameliorating a reduction in growth hormone ("GH") and/or insulin-like growth factor 1 ("IGF-1") during aging.

22. A nutraceutical formulation according to any of claims 1, 12, 14-20, wherein the colostrum is bovine colostrum.

23. A formulation for human healthcare, in a dosage range of between 3g and 8g, comprising:

phytosterol 200mg to 2500 mg;

600mg to 2600mg of an equivalent of polygonum multiflorum root extracted with 70% ethanol aqueous solution at a ratio of 4: 1;

methylsulfonylmethane 500mg to 2000 mg; and

bovine colostrum 500mg to 2000 mg.

24. A formulation for health care according to claim 23, wherein the formulation further comprises 50mg to 1000mg of an equivalent of the ginkgo biloba extract extracted with 70% aqueous ethanol at a ratio of 50: 1.

25. A formulation for healthcare according to claim 23 or 24 wherein the formulation further comprises 10mg to 40mg of a 20% equivalent of zinc amino acid chelate.

26. A formulation for health use according to any one of claims 23 to 25, wherein the formulation comprises any one or more of the following components:

120mg to 500mg of arginine;

biotin 0.7mg to 5 mg;

5mg to 30mg of nicotinic acid;

10mg to 400mg of calcium pantothenate;

pyridoxine hydrochloride from 10mg to 400 mg;

200IU to 800IU of d-alpha-tocopheryl acetate; and

60mg to 500mg of anhydrous colloidal silica.

27. A formulation for health use according to any one of claims 23 to 26, wherein the formulation further comprises any one or more of the following components:

an equivalent of soybean (Glycine Max) seed extracted 65: 1 with 75% aqueous ethanol from 80mg to 3250 mg;

50mg to 1000mg of American ginseng (Panax quinquefolium) root extract is extracted by 15 percent ethanol water solution according to the ratio of 3: 1;

50mg to 1000mg of an extract of Equisetum arvense (Equisetum arvense) extracted with 100% water at a ratio of 4: 1;

inositol 70 mg-300 mg.

28. A formulation for health use according to claim 27, wherein the phytosterol is in the range of 200mg to 2500 mg.

29. A formulation for health use according to claim 27, wherein the phytosterol is in the range of 200mg to 1000 mg.

30. A nutraceutical formulation according to claim 27 when dependent on any of claims 24-26, wherein said ginkgo extract is in the range of 50mg to 1000 mg.

31. A nutraceutical formulation according to claim 27 when dependent on any of claims 24-26, wherein said ginkgo extract is in the range of 50mg to 500 mg.

32. A formulation for health care according to claim 27, wherein the extract of the roots of panax quinquefolius is 50mg to 1000 mg.

33. A formulation for health care according to claim 27, wherein the extract of the roots of panax quinquefolius is 50mg to 500 mg.

34. A healthcare preparation according to claim 27, wherein the horsetail extract is 50mg to 1000 mg.

35. A healthcare preparation according to claim 27, wherein the horsetail extract is 50mg to 500 mg.

36. A nutraceutical formulation according to claim 27, wherein the bovine colostrum is 50mg to 2000 mg.

37. A nutraceutical formulation according to claim 27, wherein the bovine colostrum is 500mg to 1000 mg.

38. A formulation for health care according to claim 26, wherein the biotin is 0.7mg to 3 mg.

39. The formulation for health use according to claim 26, wherein the pyridoxine hydrochloride is 100mg to 400 mg.

40. A formulation for health use according to any one of claims 27 to 39, comprising 6 to 26mg of Trusil natural lemon/lime.

41. A formulation for health protection according to any one of claims 27 to 39, comprising from 125mg to 500mg of fructose.

42. A formulation for health care of a human patient, the formulation comprising:

providing a biological sulfur nutritional supplement of biologically active sulfur;

one or more dihydrotestosterone blocking components for inhibiting the binding of dihydrotestosterone to a receptor site and/or inhibiting the effect of 5-alpha-reductase in converting testosterone to dihydrotestosterone;

one or more capillary blood flow promoting agents for promoting capillary blood flow;

a growth factor component that promotes cell growth by ameliorating the reduction of growth hormone ("GH") and/or insulin-like growth factor 1 ("IGF-1") during aging;

an amino acid component having at least some of all the essential amino acids for human metabolism; and

at least the minerals silicon and zinc are introduced into the mineral composition of the patient.

43. A formulation for health care in accordance with claim 42, wherein said formulation includes a formulation having at least a portion of vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B8, vitamin B_xAnd vitamin component of vitamin E.

44. A formulation for health use according to claim 42 or 43, wherein the ingredient is selected from the group consisting of phytosterols, Polygonum multiflorum root (fo-ti), soybean seed, Ginkgo biloba leaf, Panax quinquefolium root, Equisetum arvense, inositol, methylsulfonylmethane, bovine colostrum, arginine, biotin, niacin, calcium pantothenate, pyridoxine hydrochloride, d-alpha-tocopheryl acetate, Trusil lemon/lime or an equivalent flavouring agent, fructose or an equivalent sweetening agent, anhydrous colloidal silica and zinc amino acid chelate, formulated in a dose of 3g to 8g according to claim 23.

45. A formulation for health care according to any one of claims 42 to 44, wherein the amino acid component comprises isoflavones.

46. A nutraceutical formulation according to any of claims 42-44, wherein the amino acid component comprises phytosterols.

47. A nutraceutical formulation according to any of claims 42-44, wherein the amino acid component comprises phytoestrogens.

48. A formulation for health care according to any one of claims 42 to 44, wherein the amino acid component comprises genistein.

49. A nutraceutical formulation according to any of claims 42-44, wherein the amino acid component comprises daidzein.

50. A human healthcare medical preparation, the preparation comprising:

extracts of the following herbs:

polygoni Multiflori radix;

ginkgo biloba;

herba Equiseti Arvinsis;

american ginseng;

methylsulfonylmethane;

l-arginine;

inhibitors of 5-alpha-reductase production;

one or more soy isoflavones;

inositol;

nicotinic acid;

biotin;

calcium pantothenate;

d-alpha-tocopherol;

pyridoxine hydrochloride;

amino acid chelated zinc; and

colostrum.

51. A formulation for patient care, said formulation comprising, at a dosage ranging between 3g and 8 g:

phytosterol 200mg to 2500 mg;

600mg to 2600mg of equivalent polygonum multiflorum root extracted with 70% ethanol water solution according to a ratio of 4: 1;

800mg to 3250mg of equivalent of soybean seeds extracted by 75% ethanol water solution according to a ratio of 65: 1;

50 mg-1000 mg of the equivalent of the ginkgo biloba extract extracted with 70% ethanol water solution according to the ratio of 50: 1

50mg to 1000mg of the same amount of the American ginseng root extract extracted by 15% ethanol water solution according to the ratio of 3: 1;

50mg to 1000mg of an equivalent of an Equisetum arvense extract extracted with 100% water at a ratio of 4: 1;

inositol 70 mg-300 mg;

methylsulfonylmethane 500mg to 2000 mg;

bovine colostrum 500mg to 2000 mg;

120mg to 500mg of arginine;

biotin 0.7mg to 5 mg;

5mg to 30mg of nicotinic acid;

calcium pantothenate in an amount of 100mg to 400 mg;

pyridoxine hydrochloride from 10mg to 400 mg;

200IU to 800IU of d-alpha-tocopheryl acetate;

6 to 26mg or equivalent of Trusil natural lemon/lime flavoring;

fructose 125mg to 500mg or a sweetener equivalent thereto;

60-500 mg of anhydrous colloidal silica;

amino acid chelated zinc 20% equivalent 10mg to 40 mg.

52. A method of improving the health of a human patient comprising the steps of:

preparing a predetermined amount of a preparation consisting of extracts of the herbs polygonum multiflorum, panax quinquefolium, ginkgo biloba, and equisetum arvense; beta-sitosterol; methylsulfonylmethane; soy isoflavones; l-arginine; inositol; nicotinic acid; pantothenic acid or salts thereof; alpha-tocopherol; biotin; pyridoxine hydrochloride; zinc (or its amino acid chelate) and colostrum; and is

The amounts are prepared for oral administration to a human patient.

53. A method of improving the health of a human patient comprising the steps of:

preparing a predetermined amount of a formulation consisting of: providing a biological sulfur nutritional supplement of biologically active sulfur; one or more capillary blood flow promoting agents for promoting capillary blood flow; by ameliorating growth hormone ("GH") and/or pancreas during agingA growth factor component that reduces insulin-like growth factor 1 ("IGF-1") and thereby promotes cell growth; an amino acid component having at least some of all the essential amino acids for human metabolism; a mineral component for introducing at least the minerals silicon and zinc into the patient; and has at least a portion of vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B8, vitamin B_xAnd vitamin E; and is

The predetermined amount is prepared for oral administration to a patient.